Search Videos and More

Showing 169 - 180 of 551 results

Previous| 1... 14 | 15 | 16 ...46 |Next


Telehealth Can Significantly Reduce Greenhouse Gas Emissions Associated with Cancer Care, Study Finds News

Telehealth Can Significantly Reduce Greenhouse Gas Emissions Associated with Cancer Care, Study Finds

Telemedicine visits for cancer care may not only be more convenient and easier to schedule than in-person appointments, they're also better for the planet, new research by Dana-Farber Cancer Institute scientists shows.
AACR 2024 Highlights Symposium

AACR 2024 Highlights

Review presentations and information shared by Dana-Farber physician-scientists at the 2024 American Association of Cancer Research (AACR) Annual Meeting held April 5-10, San Diego, CA.
Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots News

Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots

Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma.
Dana-Farber Researchers Discover New Target for Potential Leukemia Therapy News

Dana-Farber Researchers Discover New Target for Potential Leukemia Therapy

A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival.
Most Young Women Treated For Breast Cancer Can Have Children, Study Shows News

Most Young Women Treated For Breast Cancer Can Have Children, Study Shows

In a study of nearly 200 young women who have survived breast cancer, most of those who tried to conceive were able to become pregnant and give birth.
2024 American Society of Clinical Oncology (ASCO) Symposium

2024 American Society of Clinical Oncology (ASCO)

Review presentations, oral abstracts, and other information shared by Dana-Farber physician-scientists at the ASCO 2024 Annual Meeting.
New $15 Million Grant to Dana-Farber Scientists Supports Research into Innovative Approaches to Endometrial Cancer Treatment News

New $15 Million Grant to Dana-Farber Scientists Supports Research into Innovative Approaches to Endometrial Cancer Treatment

Physician-scientists at Dana-Farber Cancer Institute have received a five-year, $15 million Program Project Grant from the National Cancer Institute (NCI) for research in endometrial cancer, which arises in the inner lining of the uterus and strikes more than 68,000 women a year in the U.S.
Dana-Farber Research Publication 05.01.2024 News

Dana-Farber Research Publication 05.01.2024

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Unraveling the Menin Mystery to Halt Cancer Growth News

Unraveling the Menin Mystery to Halt Cancer Growth

The story of research in menin and its relation to cancer — from early efforts to understand how the cell makes use of menin, to explorations of the cell machinery operated by menin, to the development and testing of agents that inhibit menin, to work on preventing resistance to such agents — weaves through Dana-Farber at every step.
Dana-Farber Researchers Explore AI's Potential Roles in Predicting and Diagnosing Cancer News

Dana-Farber Researchers Explore AI's Potential Roles in Predicting and Diagnosing Cancer

In 2022 and 2023, you couldn't go a day without hearing about artificial intelligence (AI). Generative AI tools such as chatbots and art generators had become a central topic in everyday conversations. But AI in cancer has deeper roots. Twenty-five years before ChatGPT burst onto the scene, computers started playing a larger role in cancer diagnostics. In 1997, mammograms weren't even digital yet, but computers had started analyzing them. The tools, called expert systems, used hard-coded logic to read digital images of X-ray-based mammograms to look for signs of cancer.
Use of Low-Dose Tamoxifen in Patients with Estrogen Receptor-Positive (ER+) Ductal Carcinoma in Situ (DCIS) Document

Use of Low-Dose Tamoxifen in Patients with Estrogen Receptor-Positive (ER+) Ductal Carcinoma in Situ (DCIS)

The Breast Oncology Center at Dana-Farber Brigham Cancer Center developed expert-based consensus recommendations for the use of low-dose tamoxifen in patients with Ductal Carcinoma in Situ (DCIS).
Ancient DNA Reveals Origin of Racial/Ethnic Disparity in a Childhood Cancer News

Ancient DNA Reveals Origin of Racial/Ethnic Disparity in a Childhood Cancer

There are 40% more Hispanic/Latino kids diagnosed with acute lymphoblastic leukemia (ALL) than white non-Hispanic/Latino children; actually, Hispanic/Latino individuals have the highest risk of ALL in the United States. However, the basis for this difference is not well understood. Researchers recently identified a genetic variant that accounts for the increased risk of B-cell ALL in Hispanic/Latino children, and using ancient DNA, they traced the mutation all the way back to the first migrants who entered the Americas ~13,000 years ago.

Showing 169 - 180 of 551 results

Previous| 1... 14 | 15 | 16 ...46 |Next